DreamCIS

DreamCIS EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of DreamCIS (223250.KQ) as of Oct 29, 2026 is 10.59. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -71.96 — a change of -114.71% (higher).

EV/FCF

10.59

YoY

-114.71%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of DreamCIS is 2025 10.59 . EV/FCF (Enterprise Value to Free Cash Flow) of DreamCIS was 2024 -71.96 . It decreases by -114.71% higher compared to the previous year.

The DreamCIS EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
28.12 KRW
Jan 1, 2019
31.10 KRW
Jan 1, 2020
35.29 KRW
Jan 1, 2021
23.55 KRW
Jan 1, 2022
14.58 KRW
Jan 1, 2023
21.95 KRW
Jan 1, 2024
-71.96 KRW
Jan 1, 2025
10.59 KRW
The DreamCIS EV/FCF history
YEAREV/FCFYoY
10.59-114.71%
-71.96-427.87%
21.95+50.50%
14.58-38.07%
23.55-33.28%
35.29+13.48%
31.10+10.58%
28.12-66.53%
84.03—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DreamCIS Stock analysis

What does DreamCIS do? DreamCIS Inc. is a company based in Seoul, South Korea, operating within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company went public on May 22, 2020, with its stock listed under the ticker 223250.KQ and ISIN KR7223250002. DreamCIS Inc. provides clinical online information and consultation services, focusing on regulatory post-marketing surveillance (rPMS), clinical trials, and non-interventional studies (NIS). The company serves both domestic and international markets, offering its services to clients seeking support in clinical research and regulatory compliance. Its headquarters are located in Seoul, South Korea. The company's website is http://www.dreamcis.com/, which serves as a primary source for further information about its services and operations. DreamCIS Inc. does not provide detailed information about its founding year, specific leadership, or financial figures beyond its IPO date, and no acquisitions or additional product names are mentioned in the provided data. The company's services are primarily aimed at facilitating clinical research and ensuring adherence to regulatory standards in the life sciences sector. DreamCIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DreamCIS stock

EV/FCF (Enterprise Value to Free Cash Flow) of DreamCIS is 10.59 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of DreamCIS changed from -71.96 to 10.59, representing a -114.71% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) DreamCIS since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s DreamCIS with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — DreamCIS

All Key Metrics — DreamCIS